Morepen Laboratories バランスシートの健全性
財務の健全性 基準チェック /66
Morepen Laboratoriesの総株主資本は₹11.1B 、総負債は₹334.9Mで、負債比率は3%となります。総資産と総負債はそれぞれ₹15.6Bと₹4.5Bです。 Morepen Laboratoriesの EBIT は₹1.8Bで、利息カバレッジ比率65.5です。現金および短期投資は₹1.9Bです。
主要情報
3.0%
負債資本比率
₹334.95m
負債
| インタレスト・カバレッジ・レシオ | 65.5x |
| 現金 | ₹1.86b |
| エクイティ | ₹11.10b |
| 負債合計 | ₹4.52b |
| 総資産 | ₹15.62b |
財務の健全性に関する最新情報
Does Morepen Laboratories (NSE:MOREPENLAB) Have A Healthy Balance Sheet?
Jun 13
Morepen Laboratories (NSE:MOREPENLAB) Seems To Use Debt Quite Sensibly
Nov 23Is Morepen Laboratories (NSE:MOREPENLAB) Using Too Much Debt?
Aug 10Is Morepen Laboratories (NSE:MOREPENLAB) Using Too Much Debt?
May 21Morepen Laboratories (NSE:MOREPENLAB) Has A Pretty Healthy Balance Sheet
Jan 03
Recent updates
There's Reason For Concern Over Morepen Laboratories Limited's (NSE:MOREPENLAB) Massive 30% Price Jump
Aug 20Impressive Earnings May Not Tell The Whole Story For Morepen Laboratories (NSE:MOREPENLAB)
Aug 09Improved Earnings Required Before Morepen Laboratories Limited (NSE:MOREPENLAB) Stock's 29% Jump Looks Justified
Jul 05Does Morepen Laboratories (NSE:MOREPENLAB) Have A Healthy Balance Sheet?
Jun 13Morepen Laboratories Limited's (NSE:MOREPENLAB) Popularity With Investors Is Under Threat From Overpricing
Apr 23Morepen Laboratories (NSE:MOREPENLAB) Seems To Use Debt Quite Sensibly
Nov 23Increases to CEO Compensation Might Be Put On Hold For Now at Morepen Laboratories Limited (NSE:MOREPENLAB)
Sep 22Is Morepen Laboratories (NSE:MOREPENLAB) Using Too Much Debt?
Aug 10Increases to CEO Compensation Might Be Put On Hold For Now at Morepen Laboratories Limited (NSE:MOREPENLAB)
Sep 21Should You Be Adding Morepen Laboratories (NSE:MOREPENLAB) To Your Watchlist Today?
Apr 05Do Morepen Laboratories's (NSE:MOREPENLAB) Earnings Warrant Your Attention?
Sep 14Is Morepen Laboratories (NSE:MOREPENLAB) Using Too Much Debt?
May 21Does Morepen Laboratories (NSE:MOREPENLAB) Deserve A Spot On Your Watchlist?
Mar 12Our View On Morepen Laboratories' (NSE:MOREPENLAB) CEO Pay
Feb 22Is Morepen Laboratories Limited's (NSE:MOREPENLAB) Stock's Recent Performance Being Led By Its Attractive Financial Prospects?
Feb 07Morepen Laboratories (NSE:MOREPENLAB) Shareholders Have Enjoyed A 91% Share Price Gain
Jan 21Morepen Laboratories (NSE:MOREPENLAB) Has A Pretty Healthy Balance Sheet
Jan 03Is There More To The Story Than Morepen Laboratories's (NSE:MOREPENLAB) Earnings Growth?
Dec 16Should You Be Adding Morepen Laboratories (NSE:MOREPENLAB) To Your Watchlist Today?
Nov 28財務状況分析
短期負債: MOREPENLABの 短期資産 ( ₹10.9B ) が 短期負債 ( ₹4.1B ) を超えています。
長期負債: MOREPENLABの短期資産 ( ₹10.9B ) が 長期負債 ( ₹453.2M ) を上回っています。
デット・ツー・エクイティの歴史と分析
負債レベル: MOREPENLAB総負債よりも多くの現金を保有しています。
負債の削減: MOREPENLABの負債対資本比率は、過去 5 年間で64.2%から3%に減少しました。
債務返済能力: MOREPENLABの負債は 営業キャッシュフロー によって 十分にカバー されています ( 144.2% )。
インタレストカバレッジ: MOREPENLABの負債に対する 利息支払い は EBIT ( 65.5 x coverage) によって 十分にカバーされています。